Tag Archives: metabolism

Both the Metagenomics of the Human Intestinal Tract (MetaHIT) project, supported by the European Comission under the 7th Framework program, and the Human Microbiome Project (HMP), supported by the National Institutes of Health (NIH), are the largest studies to date that have characterized the microbiomes of healthy human subjects at different body sites using 16S and shotgun metagenomic sequencing. A…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Both the Metagenomics of the Human Intestinal Tract (MetaHIT) project, supported by the European Comission under the 7th Framework program, and the Human Microbiome Project (HMP), supported by the National Institutes of Health (NIH), are the largest studies to date that have characterized the microbiomes of healthy human subjects at different body sites using 16S and shotgun metagenomic sequencing. A…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Gut microbiome research has recently focused not only in gastrointestinal diseases, but also in other conditions with systemic effects beyond the gut. Cystic fibrosis (CF) is a progressive genetic disease that affects the lungs: both chloride and bicarbonate ion transport across epithelial cells in the lung are affected, but also epithelial cells located throughout the body, leading to an altered…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Gut microbiome research has recently focused not only in gastrointestinal diseases, but also in other conditions with systemic effects beyond the gut. Cystic fibrosis (CF) is a progressive genetic disease that affects the lungs: both chloride and bicarbonate ion transport across epithelial cells in the lung are affected, but also epithelial cells located throughout the body, leading to an altered…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Previous research has shown that the gut microbiome may modulate host metabolic health including the development of type 2 diabetes. However, little is known regarding the role of the gut microbiome in the aetiology of gestational diabetes mellitus (GDM), which is defined as “any degree of glucose intolerance with onset or first recognition during pregnancy”. A new study, led by…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Previous research has shown that the gut microbiome may modulate host metabolic health including the development of type 2 diabetes. However, little is known regarding the role of the gut microbiome in the aetiology of gestational diabetes mellitus (GDM), which is defined as “any degree of glucose intolerance with onset or first recognition during pregnancy”. A new study, led by…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

There’s no such thing as one-size-fits-all nutrition. In 2015, researchers from the Weizmann Institute of Science in Israel laid the foundation for this statement with an article that proved that each of us metabolises food differently due, in part, to gut microbiota. Researcher Niv Zmora explained to Gut Microbiota for Health the main results of that study during the GMFH…

Cristina Sáez
Cristina Saez is a freelance science journalist. She works for several media, for instance the Spanish newspaper La Vanguardia, where she coordinates the science section, Big Vang; as well as research centres and scientific societies. She has been awarded for her journalistic work, among others, with the Boehringer Ingelheim Award in Medical Journalism 2015. Follow Cristina on Twitter @saez_cristina

There’s no such thing as one-size-fits-all nutrition. In 2015, researchers from the Weizmann Institute of Science in Israel laid the foundation for this statement with an article that proved that each of us metabolises food differently due, in part, to gut microbiota. Researcher Niv Zmora explained to Gut Microbiota for Health the main results of that study during the GMFH…

Cristina Sáez
Cristina Saez is a freelance science journalist. She works for several media, for instance the Spanish newspaper La Vanguardia, where she coordinates the science section, Big Vang; as well as research centres and scientific societies. She has been awarded for her journalistic work, among others, with the Boehringer Ingelheim Award in Medical Journalism 2015. Follow Cristina on Twitter @saez_cristina

It is well-known that medications could affect the microbiome and therefore host-microbiota interactions are considered a confounding factor that can contribute to therapeutic and side effects of drug treatments. Previous research has shown that gut microbiota may partially mediate both therapeutic and adverse effects of metformin, which is the most prescribed drug for the treatment of individuals with type 2…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

It is well-known that medications could affect the microbiome and therefore host-microbiota interactions are considered a confounding factor that can contribute to therapeutic and side effects of drug treatments. Previous research has shown that gut microbiota may partially mediate both therapeutic and adverse effects of metformin, which is the most prescribed drug for the treatment of individuals with type 2…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Conditions that represent some of the leading causes of mortality worldwide—including obesity, diabetes, cardiovascular disease, and cancers—are linked with observable changes in the human gut microbiota. And many other chronic conditions, like inflammatory bowel disease, asthma and allergies, rheumatoid arthritis, and even myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), have also been linked with gut microbiota dysbiosis. Scientists and the public have…

Patrice D. Cani
Professor Patrice D. Cani is researcher from the Belgian Fund for Scientific Research (FRS-FNRS), group leader in the Metabolism and Nutrition research group at the Louvain Drug Research Institute (LDRI) from the Université catholique de Louvain (UCL), Brussels, Belgium, and WELBIO (Walloon Excellence in Lifesciences and BIOtechnology) investigator. He is currently member of several international associations, he is member of the Alumni College from the Royal Belgian Academy of Sciences, and he has been elected in the board of directors of the LDRI (UCL). Patrice D. Cani has a M.Sc. in Nutrition and another M.Sc. in health Sciences, he is registered dietitian and PhD in Biomedical Sciences. His main research interests are the investigation of the role of the gut microbiota in the development of metabolic disorders, such as obesity, type 2 diabetes and low grade inflammation. More specifically, he is investigating the interactions between the gut microbiota, the host and specific biological systems such as the endocannabinoid system and the innate immune system in the context of obesity, type 2 diabetes and metabolic inflammation. Prof Cani is author and co-author of more than 110 scientific research papers published in peer-reviewed international journals, conferences and book chapters.

Conditions that represent some of the leading causes of mortality worldwide—including obesity, diabetes, cardiovascular disease, and cancers—are linked with observable changes in the human gut microbiota. And many other chronic conditions, like inflammatory bowel disease, asthma and allergies, rheumatoid arthritis, and even myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), have also been linked with gut microbiota dysbiosis. Scientists and the public have…

Patrice D. Cani
Professor Patrice D. Cani is researcher from the Belgian Fund for Scientific Research (FRS-FNRS), group leader in the Metabolism and Nutrition research group at the Louvain Drug Research Institute (LDRI) from the Université catholique de Louvain (UCL), Brussels, Belgium, and WELBIO (Walloon Excellence in Lifesciences and BIOtechnology) investigator. He is currently member of several international associations, he is member of the Alumni College from the Royal Belgian Academy of Sciences, and he has been elected in the board of directors of the LDRI (UCL). Patrice D. Cani has a M.Sc. in Nutrition and another M.Sc. in health Sciences, he is registered dietitian and PhD in Biomedical Sciences. His main research interests are the investigation of the role of the gut microbiota in the development of metabolic disorders, such as obesity, type 2 diabetes and low grade inflammation. More specifically, he is investigating the interactions between the gut microbiota, the host and specific biological systems such as the endocannabinoid system and the innate immune system in the context of obesity, type 2 diabetes and metabolic inflammation. Prof Cani is author and co-author of more than 110 scientific research papers published in peer-reviewed international journals, conferences and book chapters.

Without exception, a diagnosis of celiac disease (CD; an autoimmune reaction to eating gluten) comes with a life sentence of wheat and gluten avoidance. Even small amounts of gluten for those with CD can trigger a reaction that damages the lining of the small intestine and sometimes causes uncomfortable gastrointestinal symptoms. But since avoiding every last trace of wheat can…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

Without exception, a diagnosis of celiac disease (CD; an autoimmune reaction to eating gluten) comes with a life sentence of wheat and gluten avoidance. Even small amounts of gluten for those with CD can trigger a reaction that damages the lining of the small intestine and sometimes causes uncomfortable gastrointestinal symptoms. But since avoiding every last trace of wheat can…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

For many humans affected by obesity, the challenge of initial weight loss is less than the challenge of maintaining the weight loss over the long term. Studies in large populations have found that, while long-term maintenance of weight loss is possible, its prevalence in real life remains below satisfactory levels. Individuals may experience recurrent weight gain and re-emergence of metabolic…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

For many humans affected by obesity, the challenge of initial weight loss is less than the challenge of maintaining the weight loss over the long term. Studies in large populations have found that, while long-term maintenance of weight loss is possible, its prevalence in real life remains below satisfactory levels. Individuals may experience recurrent weight gain and re-emergence of metabolic…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

Alzheimer’s disease (AD) is an inflammatory condition considered one of the most common forms of senile dementia, and previous research in mice has shown that changes in gut bacteria could enhance inflammation and amyloidosis. Besides this, metabolic alterations such as insulin resistance and glucose metabolism dysregulation and altered lipid metabolism have also been linked to the development of AD. Studies…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Alzheimer’s disease (AD) is an inflammatory condition considered one of the most common forms of senile dementia, and previous research in mice has shown that changes in gut bacteria could enhance inflammation and amyloidosis. Besides this, metabolic alterations such as insulin resistance and glucose metabolism dysregulation and altered lipid metabolism have also been linked to the development of AD. Studies…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Previous studies have identified Akkermansia muciniphila as an important bacterium in metabolic health—able to prevent the development of obesity in animal models. Until now, however, its mechanisms were unclear and its effects had never been tested in humans. Now, a team led by Patrice D. Cani of Université catholique de Louvain (UCL; Belgium) and Willem de Vos of Wageningen University…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

Previous studies have identified Akkermansia muciniphila as an important bacterium in metabolic health—able to prevent the development of obesity in animal models. Until now, however, its mechanisms were unclear and its effects had never been tested in humans. Now, a team led by Patrice D. Cani of Université catholique de Louvain (UCL; Belgium) and Willem de Vos of Wageningen University…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter